Payment overview · 2025
General Payments
$14.32
1 reported records · 1 companies
Healthcare provider profile · identity verified
John Conway Ropp, M.D.
Allopathic & Osteopathic Physicians|Family Medicine · HARTSVILLE, SC · NPI 1922037191
Verified facts
What the public records show
CMS Open Payments records show John Conway Ropp, M.D. received $14.32 in general payments during 2025 across 1 reported records.
Amgen Inc. accounted for 100.0% of that reported general-payment amount.
The Open Payments records used for this analysis explicitly named 2 associated products.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
Companies in 2025 General Payments
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| Amgen Inc. | Unresolved — no canonical attribution shown | $14.32 | 100.0% | 1 | 2025 |
What were the payments for?
Payment categories
| Category | Amount | Records |
|---|---|---|
| Food and Beverage | $14.32 | 1 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
Products named in Open Payments records
| Reported product | Type | Reported company | Related amount* | Records | Year |
|---|---|---|---|---|---|
| OTEZLA Normalized: otezla |
Drug | Amgen Inc. | $14.32 | 1 | 2025 |
Source payment records
|
|||||
| REPATHA Normalized: repatha |
Biological | Amgen Inc. | $14.32 | 1 | 2025 |
Source payment records
|
|||||
* Product-associated amounts are non-additive because one payment record may name more than one product.
These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.
Public prescribing for products named in payments
No exact normalized or approved-alias overlap was found in the loaded Part D year. This does not mean the doctor never prescribed the product.
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
No publishable same-company prescribing overlap was found in the loaded Part D year. This does not mean the doctor never prescribed a drug reported elsewhere by a paying company.
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Oxycodone-Acetaminophen | Oxycodone Hcl/Acetaminophen | 1195 | 131 |
| Hydrocodone-Acetaminophen | Hydrocodone/Acetaminophen | 980 | 126 |
| Clonazepam | Clonazepam | 759 | 103 |
| Gabapentin | Gabapentin | 703 | 126 |
| Amlodipine Besylate | Amlodipine Besylate | 550 | 144 |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 415 | 125 |
| Omeprazole | Omeprazole | 393 | 102 |
| Zolpidem Tartrate | Zolpidem Tartrate | 323 | 47 |
| Alprazolam | Alprazolam | 313 | 45 |
| Levothyroxine Sodium | Levothyroxine Sodium | 307 | 73 |
| Pantoprazole Sodium | Pantoprazole Sodium | 286 | 90 |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 278 | 72 |
| Atorvastatin Calcium | Atorvastatin Calcium | 269 | 77 |
| Lisinopril | Lisinopril | 265 | 67 |
| Meloxicam | Meloxicam | 261 | 79 |
| Furosemide | Furosemide | 235 | 74 |
| Metoprolol Succinate | Metoprolol Succinate | 231 | 66 |
| Oxycodone Hcl | Oxycodone Hcl | 226 | 31 |
| Losartan Potassium | Losartan Potassium | 211 | 55 |
| Hydroxyzine Hcl | Hydroxyzine Hcl | 201 | 87 |
| Metformin Hcl | Metformin Hcl | 200 | 49 |
| Jardiance | Empagliflozin | 197 | 43 |
| Escitalopram Oxalate | Escitalopram Oxalate | 192 | 51 |
| Cyclobenzaprine Hcl | Cyclobenzaprine Hcl | 188 | 47 |
| Quetiapine Fumarate | Quetiapine Fumarate | 169 | 41 |
| Lorazepam | Lorazepam | 163 | 35 |
| Montelukast Sodium | Montelukast Sodium | 161 | 47 |
| Trazodone Hcl | Trazodone Hcl | 158 | 46 |
| Potassium Chloride | Potassium Chloride | 154 | 46 |
| Trulicity | Dulaglutide | 143 | 24 |
| Dextroamphetamine-Amphetamine | Dextroamphetamine/Amphetamine | 142 | 15 |
| Naproxen | Naproxen | 139 | 47 |
| Promethazine Hcl | Promethazine Hcl | 139 | 29 |
| Metoprolol Tartrate | Metoprolol Tartrate | 128 | 34 |
| Pregabalin | Pregabalin | 128 | 29 |
| Hydrochlorothiazide | Hydrochlorothiazide | 127 | 35 |
| Sertraline Hcl | Sertraline Hcl | 125 | 30 |
| Ozempic | Semaglutide | 124 | 27 |
| Diclofenac Sodium | Diclofenac Sodium | 119 | 48 |
| Pravastatin Sodium | Pravastatin Sodium | 118 | 34 |
| Ibuprofen | Ibuprofen | 108 | 29 |
| Ondansetron Hcl | Ondansetron Hcl | 107 | 45 |
| Clopidogrel | Clopidogrel Bisulfate | 106 | 35 |
| Azithromycin | Azithromycin | 104 | 79 |
| Eliquis | Apixaban | 103 | 25 |
| Lisinopril-Hydrochlorothiazide | Lisinopril/Hydrochlorothiazide | 103 | 33 |
| Fluconazole | Fluconazole | 99 | 62 |
| Mounjaro | Tirzepatide | 98 | 19 |
| Prednisone | Prednisone | 98 | 51 |
| Citalopram Hbr | Citalopram Hydrobromide | 95 | 24 |
| Carvedilol | Carvedilol | 94 | 24 |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 92 | 16 |
| Buspirone Hcl | Buspirone Hcl | 84 | 43 |
| Tizanidine Hcl | Tizanidine Hcl | 84 | 25 |
| Naloxone Hcl | Naloxone Hcl | 81 | 59 |
| Propranolol Hcl | Propranolol Hcl | 80 | 15 |
| Amoxicillin | Amoxicillin | 77 | 60 |
| Fluoxetine Hcl | Fluoxetine Hcl | 71 | 19 |
| Temazepam | Temazepam | 71 | 11 |
| Linzess | Linaclotide | 70 | 23 |
| Trelegy Ellipta | Fluticasone/Umeclidin/Vilanter | 69 | 14 |
| Mirtazapine | Mirtazapine | 65 | 15 |
| Solifenacin Succinate | Solifenacin Succinate | 65 | 19 |
| Fluticasone Propionate | Fluticasone Propionate | 64 | 22 |
| Tamsulosin Hcl | Tamsulosin Hcl | 61 | 15 |
| Isosorbide Mononitrate Er | Isosorbide Mononitrate | 59 | 18 |
| Tramadol Hcl | Tramadol Hcl | 58 | 12 |
| Diazepam | Diazepam | 54 | suppressed |
| Duloxetine Hcl | Duloxetine Hcl | 54 | 15 |
| Triamcinolone Acetonide | Triamcinolone Acetonide | 54 | 27 |
| Metformin Hcl Er | Metformin Hcl | 53 | 22 |
| Esomeprazole Magnesium | Esomeprazole Magnesium | 52 | 18 |
| Simvastatin | Simvastatin | 52 | 16 |
| Famotidine | Famotidine | 50 | 13 |
| Mupirocin | Mupirocin | 50 | 34 |
| Synthroid | Levothyroxine Sodium | 50 | 12 |
| Clonidine Hcl | Clonidine Hcl | 49 | 11 |
| Venlafaxine Hcl Er | Venlafaxine Hcl | 48 | 11 |
| Ropinirole Hcl | Ropinirole Hcl | 47 | suppressed |
| Losartan-Hydrochlorothiazide | Losartan/Hydrochlorothiazide | 46 | 11 |
| Colchicine | Colchicine | 45 | 14 |
| Memantine Hcl | Memantine Hcl | 45 | suppressed |
| Sulfamethoxazole-Trimethoprim | Sulfamethoxazole/Trimethoprim | 43 | 37 |
| Celecoxib | Celecoxib | 42 | suppressed |
| Cephalexin | Cephalexin | 42 | 21 |
| Paroxetine Hcl | Paroxetine Hcl | 41 | 11 |
| Bupropion Xl | Bupropion Hcl | 40 | 13 |
| Levetiracetam | Levetiracetam | 39 | suppressed |
| Morphine Sulfate Er | Morphine Sulfate | 39 | suppressed |
| Glipizide | Glipizide | 38 | 11 |
| Donepezil Hcl | Donepezil Hcl | 37 | suppressed |
| Hydroxyzine Pamoate | Hydroxyzine Pamoate | 37 | suppressed |
| Irbesartan | Irbesartan | 37 | suppressed |
| Dexlansoprazole Dr | Dexlansoprazole | 35 | suppressed |
| Aripiprazole | Aripiprazole | 34 | suppressed |
| Acetaminophen-Codeine | Acetaminophen With Codeine | 33 | suppressed |
| Ciprofloxacin Hcl | Ciprofloxacin Hcl | 33 | 19 |
| Divalproex Sodium Er | Divalproex Sodium | 32 | suppressed |
| Myrbetriq | Mirabegron | 32 | suppressed |
| Eszopiclone | Eszopiclone | 31 | suppressed |
| Farxiga | Dapagliflozin Propanediol | 30 | suppressed |
| Humulin 70/30 Kwikpen | Insulin Nph Hum/Reg Insulin Hm | 30 | suppressed |
| Carisoprodol | Carisoprodol | 29 | suppressed |
| Nifedipine Er | Nifedipine | 29 | suppressed |
| Humalog Kwikpen U-100 | Insulin Lispro | 28 | suppressed |
| Combivent Respimat | Ipratropium/Albuterol Sulfate | 27 | suppressed |
| Hydralazine Hcl | Hydralazine Hcl | 27 | suppressed |
| Methocarbamol | Methocarbamol | 27 | suppressed |
| Chlorthalidone | Chlorthalidone | 26 | suppressed |
| Levocetirizine Dihydrochloride | Levocetirizine Dihydrochloride | 26 | suppressed |
| Meclizine Hcl | Meclizine Hcl | 26 | 11 |
| Tresiba Flextouch U-100 | Insulin Degludec | 26 | suppressed |
| Finasteride | Finasteride | 25 | suppressed |
| Levofloxacin | Levofloxacin | 25 | 21 |
| Oxycontin | Oxycodone Hcl | 25 | suppressed |
| Terbinafine Hcl | Terbinafine Hcl | 25 | suppressed |
| Amlodipine Besylate-Benazepril | Amlodipine Besylate/Benazepril | 24 | suppressed |
| Diltiazem Hcl | Diltiazem Hcl | 24 | suppressed |
| Spironolactone | Spironolactone | 24 | suppressed |
| Topiramate | Topiramate | 24 | suppressed |
| Triazolam | Triazolam | 24 | suppressed |
| Warfarin Sodium | Warfarin Sodium | 24 | suppressed |
| Benazepril Hcl | Benazepril Hcl | 23 | suppressed |
| Metoclopramide Hcl | Metoclopramide Hcl | 23 | suppressed |
| Klor-Con M20 | Potassium Chloride | 22 | suppressed |
| Ventolin Hfa | Albuterol Sulfate | 22 | suppressed |
| Entresto | Sacubitril/Valsartan | 21 | suppressed |
| Sucralfate | Sucralfate | 21 | suppressed |
| Sumatriptan Succinate | Sumatriptan Succinate | 21 | suppressed |
| Xarelto | Rivaroxaban | 21 | suppressed |
| Acyclovir | Acyclovir | 20 | suppressed |
| Atenolol | Atenolol | 20 | suppressed |
| Allopurinol | Allopurinol | 19 | suppressed |
| Divalproex Sodium | Divalproex Sodium | 19 | suppressed |
| Haloperidol | Haloperidol | 19 | suppressed |
| Hydromorphone Hcl | Hydromorphone Hcl | 19 | suppressed |
| Valacyclovir | Valacyclovir Hcl | 19 | suppressed |
| Breztri Aerosphere | Budesonide/Glycopyr/Formoterol | 18 | suppressed |
| Diphenoxylate-Atropine | Diphenoxylate Hcl/Atropine | 18 | suppressed |
| Ezetimibe | Ezetimibe | 18 | suppressed |
| Premarin | Estrogens, Conjugated | 18 | suppressed |
| Tresiba Flextouch U-200 | Insulin Degludec | 18 | suppressed |
| Fluticasone-Salmeterol | Fluticasone Propion/Salmeterol | 16 | suppressed |
| Primidone | Primidone | 16 | suppressed |
| Gemfibrozil | Gemfibrozil | 15 | suppressed |
| Nitrofurantoin Mono-Macro | Nitrofurantoin Monohyd/M-Cryst | 15 | 15 |
| Doxycycline Hyclate | Doxycycline Hyclate | 14 | 12 |
| Fludrocortisone Acetate | Fludrocortisone Acetate | 14 | suppressed |
| Glimepiride | Glimepiride | 14 | suppressed |
| Mometasone Furoate | Mometasone Furoate | 14 | suppressed |
| Nabumetone | Nabumetone | 14 | suppressed |
| Ondansetron Odt | Ondansetron | 14 | suppressed |
| Atrovent Hfa | Ipratropium Bromide | 13 | suppressed |
| Fenofibrate | Fenofibrate Nanocrystallized | 13 | suppressed |
| Ubrelvy | Ubrogepant | 13 | suppressed |
| Benztropine Mesylate | Benztropine Mesylate | 12 | suppressed |
| Clorazepate Dipotassium | Clorazepate Dipotassium | 12 | suppressed |
| Fentanyl | Fentanyl | 12 | suppressed |
| Ipratropium Bromide | Ipratropium Bromide | 12 | suppressed |
| Oxybutynin Chloride | Oxybutynin Chloride | 12 | suppressed |
| Paliperidone Er | Paliperidone | 12 | suppressed |
| Quetiapine Fumarate Er | Quetiapine Fumarate | 12 | suppressed |
| Rybelsus | Semaglutide | 12 | suppressed |
| Sulindac | Sulindac | 12 | suppressed |
| Symbicort | Budesonide/Formoterol Fumarate | 12 | suppressed |
| Testosterone Cypionate | Testosterone Cypionate | 12 | suppressed |
| Valsartan | Valsartan | 12 | suppressed |
| Amitriptyline Hcl | Amitriptyline Hcl | 11 | suppressed |
| Budesonide-Formoterol Fumarate | Budesonide/Formoterol Fumarate | 11 | suppressed |
| Incruse Ellipta | Umeclidinium Bromide | 11 | suppressed |
| Levemir Flexpen | Insulin Detemir | 11 | suppressed |
| Lovastatin | Lovastatin | 11 | suppressed |
| Megestrol Acetate | Megestrol Acetate | 11 | suppressed |
| Methimazole | Methimazole | 11 | suppressed |
| Novolin 70-30 Flexpen | Insulin Nph Hum/Reg Insulin Hm | 11 | suppressed |
| Prempro | Estrogen,con/M-Progest Acet | 11 | suppressed |
| Ziprasidone Hcl | Ziprasidone Hcl | 11 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $14.32 · 1 records | Amgen Inc. | OTEZLA, REPATHA | — | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error